Novo Nordisk spikes as novel obesity drug causes up to 22% of weight loss
hapabapa/iStock Editorial via Getty Images Novo Nordisk (NVO) shares traded sharply higher in European trading
hapabapa/iStock Editorial via Getty Images Novo Nordisk (NVO) shares traded sharply higher in European trading
Michail_Petrov-96 Shares of Allurion (NYSE:ALUR) soared 70% in post-market trading Thursday after ending the regular
Richard Drury Bank of America Securities added Booz Allen Hamilton Holding Corp. (NYSE:BAH) and Datadog
Tom Werner Medical devices stocks are in a strong position “and must be bought,” according
Carolina Rudah A new peer-reviewed study based on data from nearly 2M individuals highlights a
Grandbrothers Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted
aprott/iStock via Getty Images Novo Nordisk (NVO) announced Friday that its popular obesity therapy, semaglutide,
Bet_Noire Eli Lilly (NYSE:LLY) has received FDA approval for its drug Omvoh, also known as
Short interest for healthcare stocks in S&P 500 rose slightly in December vs. November, while
Nikolay Pandev London (UKX) +0.67% Annual inflation rate in the UK unexpectedly edged lower to